Headlands Technologies LLC bought a new stake in Direxion Daily S&P Biotech Bull 3x Shares (NYSEARCA:LABU – Free Report) during the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor bought 596 shares of the company’s stock, valued at approximately $68,000.
A number of other hedge funds have also made changes to their positions in the stock. SG Americas Securities LLC grew its stake in Direxion Daily S&P Biotech Bull 3x Shares by 82.8% in the second quarter. SG Americas Securities LLC now owns 2,142 shares of the company’s stock valued at $243,000 after purchasing an additional 970 shares in the last quarter. Foundations Investment Advisors LLC raised its position in Direxion Daily S&P Biotech Bull 3x Shares by 25.3% during the second quarter. Foundations Investment Advisors LLC now owns 4,087 shares of the company’s stock valued at $464,000 after acquiring an additional 825 shares in the last quarter. Jump Financial LLC acquired a new stake in Direxion Daily S&P Biotech Bull 3x Shares in the fourth quarter valued at approximately $521,000. McGuire Investment Group LLC grew its position in Direxion Daily S&P Biotech Bull 3x Shares by 11.4% in the first quarter. McGuire Investment Group LLC now owns 4,594 shares of the company’s stock worth $610,000 after acquiring an additional 470 shares in the last quarter. Finally, Gainplan LLC bought a new position in shares of Direxion Daily S&P Biotech Bull 3x Shares during the 1st quarter valued at $664,000.
Direxion Daily S&P Biotech Bull 3x Shares Stock Performance
Shares of NYSEARCA:LABU opened at $139.06 on Tuesday. Direxion Daily S&P Biotech Bull 3x Shares has a 1 year low of $48.40 and a 1 year high of $176.99. The firm has a fifty day moving average price of $132.23 and a 200 day moving average price of $120.84.
Direxion Daily S&P Biotech Bull 3x Shares Company Profile
The Direxion Daily S&P Biotech Bull 3X Shares (LABU) is an exchange-traded fund that is based on the S&P Biotechnology Select Industry index. The fund provides daily 3 times exposure to the S&P Biotechnology Select Industry Index. LABU was launched on May 28, 2015 and is managed by Direxion.
Read More
- Five stocks we like better than Direxion Daily S&P Biotech Bull 3x Shares
- What Is WallStreetBets and What Stocks Are They Targeting?
- Palo Alto Analysts Drive it to New Highs: 50% Upside Is Possible
- Find and Profitably Trade Stocks at 52-Week Lows
- Roblox’s Growth Beyond Kids: Stock Set for Major Moves
- Do ETFs Pay Dividends? What You Need to Know
- 5 Oversold Stocks to Buy Right Now
Receive News & Ratings for Direxion Daily S&P Biotech Bull 3x Shares Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Direxion Daily S&P Biotech Bull 3x Shares and related companies with MarketBeat.com's FREE daily email newsletter.